ProFoundTx
@profoundtx
Pioneering the expanded human proteome to reveal a universe of new medicines.
ID: 1508785666179670023
https://www.profoundtx.com/ 29-03-2022 12:38:40
60 Tweet
197 Followers
58 Following
Our CEO, John Lepore, joins colleagues at the Flagship Pioneering Studio to share what’s ahead for ProFound as we pioneer the expanded human proteome to reveal a universe of new medicines. #FlagshipJPM #JPM24
In Part 6 of #ScripsAsks “What does 2024 hold for #biopharma?”, our CEO, John Lepore, discusses new potential treatments for chronic diseases within the #DarkProteome. Learn more about how we’re illuminating novel proteins in this Scrip, Citeline Commercial article: brnw.ch/21wH9HS
Congratulations Flagship Pioneering on being named one of the world’s most innovative companies by Fast Company 3 years running! We're proud to be #FlagshipFounded as we pioneer the #darkproteome to take #BiggerLeaps for patients.
In partnership with Flagship Pioneering we’re thrilled to announce a collaboration with @Pfizer using our ProFoundry™ Platform to conduct foundational research to identify potential next-generation first-in-class therapies for the treatment of #obesity More: profoundtx.com/news-and-event…
Mark your calendars for the upcoming Longwood Healthcare Leaders #SpringMIT conference where our CEO, John Lepore, and other #biotech industry innovators will be discussing the journey of translating science into first-in-class medicines. Register here: bit.ly/3V9vxkE
Check out this article from Drew Armstrong @Endpts showcasing our first collaboration with Flagship Pioneering's Pioneering Medicines & @Pfizer harnessing our ProFoundry™ Platform to identify first-in-class medicines for #obesity treatment. Read the article here: bit.ly/4b5UhAh
In the latest episode of the BioProcess Online #BusinessOfBiotech podcast, our CEO, John Lepore, dives into our mission of pioneering the #ExpandedProteome and bringing new therapeutic possibilities to patients worldwide. Listen to the episode here: bit.ly/3A7deWv
We’re thrilled to announce FierceBiotech has selected us as a 2024 #Fierce15 #biotech company! This year we have rapidly advanced our ProFoundry™ Platform identifying novel proteins with the possibility to bring new therapeutic options to patients. More: bit.ly/3YwXMgt
Our Chief Innovation Officer Vinidhra Mani has been named a 2024 Boston Business Journal 40 under 40 honoree! Vini’s leadership & contributions since our founding have been invaluable to our rapid growth & success illuminating the #ExpandedProteome. See the full list: bit.ly/3MpEm5X
📆 Mark your calendars! Our CEO, John Lepore, is moderating a panel at the BioCentury Grand Rounds R&D conference. Listen in on the discussion to learn about the role of causal #biology in achieving preclinical validation. More: bit.ly/3MCeNhZ #BioCenturyGrandRounds